For example, small interfering RNA (siRNA) targeting Bcl-XL has been shown to decrease cell survival and sensitize cancer cells to chemotherapy, demonstrating a therapeutic approach to restoring apoptosis sensitivity [35, 36]. Here, BCL2L1 is linked to cancer.